Your session is about to expire
← Back to Search
Triamcinolone Acetonide 40mg/mL for Retinal Detachment
Study Summary
This trial is testing whether sub-tenon's irrigation with triamcinolone acetonide at the time of surgery can reduce pain, nausea/vomiting, and analgesic use caused by scleral buckle surgery.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Triamcinolone Acetonide 40mg/mL earned the endorsement of the FDA?
"There is ample evidence of Triamcinolone Acetonide 40mg/mL's safety due to its Phase 4 status, thus it was given a rating of 3."
What therapeutic purposes do practitioners typically employ Triamcinolone Acetonide 40mg/mL for?
"Triamcinolone Acetonide 40mg/mL has been utilized to manage cases of ulcerative colitis, hand-related afflictions and brain related conditions."
Could you enumerate any other tests that have been done involving Triamcinolone Acetonide 40mg/mL?
"Currently, 8 trials of Triamcinolone Acetonide 40mg/mL are in their final stages with 41 studies still active. The majority of these clinical tests take place in Columbia, Missouri; however, a total of 75 locations across the nation have launched studies on this medication."
Is it feasible to enroll in this research program presently?
"Affirmative. Per the data on clinicaltrials.gov, this trial is currently seeking volunteers who meet its criteria. It was first advertised on March 1st 2020 and has been updated most recently as of February 15th 2022; it aims to recruit 24 people from a single site for participation in this study."
What is the aggregate number of participants partaking in this research?
"Affirmative. Clinicaltrials.gov lists this trial as actively enrolling patients with a start date of 3 January 2020 and last updated on 15 February 2022. It is seeking 24 individuals at one location for participation in the study."
Share this study with friends
Copy Link
Messenger